MediWound Ltd (NAS:MDWD)

Q3 2025 Mediwound Ltd Earnings Call Transcript

Nov 20, 2025 / 01:30 PM GMT

Release Date Price: $16.86 (-5.60%)

Transcript

Key Points

Positve

MediWound Ltd (MDWD) reported a 23% year-over-year increase in revenue for Q3 2025, reaching $5.4 million.
The company has made significant progress in its SRX VLU trial, with most sites now active and enrolling patients.
MediWound Ltd (MDWD) completed the commissioning of its expanded Nexobrid manufacturing facility, increasing production capacity sixfold.
The company strengthened its balance sheet with $30 million in equity financing, providing resources for long-term growth strategies.
Nexobrid received approval in Australia for use in both adult and pediatric patients, expanding its market presence to 45 countries.

Negative

R&D expenses increased to $3.5 million in Q3 2025, up from $2.5 million in the same period in 2024, reflecting higher investment in clinical activities.
Operating loss for the quarter was $6.5 million, compared to $5.1 million in Q3 2024.
The company faces uncertainty regarding the timing of revenue from BADA and DOD-related activities due to a government shutdown.
Adjusted EBITDA loss increased to $5.4 million in Q3 2025, compared to a loss of $3.7 million in the same period in 2024.
The company is currently limited by its manufacturing capacity, which affects its ability to meet high demand in certain markets.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

MDWD.OQ - Mediwound Ltd
Q3 2025 Mediwound Ltd Earnings Call
Nov 20, 2025 / 01:30PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Good morning everyone and welcome to the Medi Wounds 3rd quarter 2025 earnings call. All participants will be in a listen-only mode. Should you need assistance, please signal a conference specialist by pressing the key followed by zero.

After today's presentation, there will be an opportunity to ask questions. To ask a question, you may press star and then 1 using a touchtone telephone. To withdraw your questions, you may press and 2.

Please also note today's event is being recorded.

And at this time I'd like to turn the floor over to Dan Ferry of.

--------------------------------------------------------------------------------
Unidentified_2 [2]
-------------------------------------------------------

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.